Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesPhase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Journal of Clinical Oncology, 11/09/09
Senzer NN et al. – The 26% response rate, with durability in both injected and uninjected lesions including visceral sites, together with the survival rates, are evidence of systemic effectiveness. This effectiveness, combined with a limited toxicity profile, warrants additional evaluation of JS1/34.5–/47–/GM–CSF in metastatic melanoma. A US Food and Drug Administration–approved phase III investigation is underway.
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pathology Review of Thin Melanoma and Melanoma in Situ in a Multidisciplinary Melanoma Clinic: Impact on Treatment Decisions
Journal of Clinical Oncology, 12/18/09
Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over)
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor